Table 1. The participants’ demographics and clinical characteristics.
| Characteristic | COVID-19 patients (N = 215) |
Non-COVID-19 individuals (N = 65) |
|---|---|---|
| Gender | ||
| Male | 75 (34.88%) | 31 (47.69%) |
| Female | 140 (65.12%) | 34 (52.31%) |
| Age, years | 49.00 (33.00, 60.00) | 34.00 (31.00, 55.00) |
| Comorbidity | 59 (27.44%) | – |
| Hypertension | 44 (20.47%) | – |
| Diabetes | 20 (9.30%) | – |
| Cardiovascular disease | 8 (3.72%) | – |
| Cerebrovascular disease | 6 (2.79%) | – |
| Chronic lung disease | 2 (0.93%) | – |
| Chronic nephrosis | 3 (1.40%) | – |
| Chronic liver disease | 4 (1.86%) | – |
| Cancer | 6 (2.79%) | – |
| Grades of disease severity | ||
| Asymptomatic | 54 (25.12%) | – |
| Mild | 8 (3.72%) | – |
| Moderate | 145 (67.44%) | – |
| Severe | 8 (3.72%) | – |
Notes:
The information on non-COVID-19 individuals’ comorbidity was not collected at the time.
COVID-19, coronavirus disease 2019.